Jean E. Lachowicz

5.4k total citations
84 papers, 4.3k citations indexed

About

Jean E. Lachowicz is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Jean E. Lachowicz has authored 84 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Molecular Biology, 39 papers in Cellular and Molecular Neuroscience and 14 papers in Organic Chemistry. Recurrent topics in Jean E. Lachowicz's work include Receptor Mechanisms and Signaling (41 papers), Neuropeptides and Animal Physiology (20 papers) and Neuroscience and Neuropharmacology Research (17 papers). Jean E. Lachowicz is often cited by papers focused on Receptor Mechanisms and Signaling (41 papers), Neuropeptides and Animal Physiology (20 papers) and Neuroscience and Neuropharmacology Research (17 papers). Jean E. Lachowicz collaborates with scholars based in United States, United Kingdom and Canada. Jean E. Lachowicz's co-authors include David R. Sibley, Frederick J. Monsma, John Drago, Ruth A. Duffy, C R Gerfen, Heinz Steiner, Mark W. Hamblin, Geoffrey B. Varty, Yong Shen and Michelle Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Jean E. Lachowicz

83 papers receiving 4.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jean E. Lachowicz United States 33 2.1k 1.9k 764 551 342 84 4.3k
Thomas A. Pugsley United States 29 2.2k 1.0× 1.9k 1.0× 1.2k 1.6× 722 1.3× 372 1.1× 98 4.4k
Marlene A. Jacobson United States 35 2.4k 1.1× 1.8k 0.9× 382 0.5× 1.9k 3.4× 444 1.3× 75 4.9k
Douglas J. Pettibone United States 32 2.0k 0.9× 1.9k 1.0× 403 0.5× 87 0.2× 727 2.1× 98 4.5k
Richard W. Ransom United States 29 2.4k 1.2× 1.9k 1.0× 660 0.9× 101 0.2× 293 0.9× 73 4.4k
Hiroshi Kase Japan 38 3.1k 1.5× 1.8k 0.9× 732 1.0× 1.6k 2.9× 465 1.4× 123 5.8k
Daphné Atlas Israel 39 3.4k 1.6× 2.1k 1.1× 217 0.3× 251 0.5× 706 2.1× 155 5.0k
Gunnar Schulte Sweden 45 3.7k 1.8× 1.7k 0.9× 161 0.2× 1.6k 2.9× 485 1.4× 112 6.1k
Diana L. Donnelly‐Roberts United States 35 2.8k 1.4× 985 0.5× 695 0.9× 1.5k 2.7× 649 1.9× 80 4.8k
Björn Kull Sweden 22 1.6k 0.8× 946 0.5× 251 0.3× 1.8k 3.3× 253 0.7× 32 3.3k
Robert H. Scannevin United States 30 3.3k 1.6× 1.6k 0.9× 262 0.3× 85 0.2× 534 1.6× 59 5.6k

Countries citing papers authored by Jean E. Lachowicz

Since Specialization
Citations

This map shows the geographic impact of Jean E. Lachowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean E. Lachowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean E. Lachowicz more than expected).

Fields of papers citing papers by Jean E. Lachowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jean E. Lachowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean E. Lachowicz. The network helps show where Jean E. Lachowicz may publish in the future.

Co-authorship network of co-authors of Jean E. Lachowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Jean E. Lachowicz. A scholar is included among the top collaborators of Jean E. Lachowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean E. Lachowicz. Jean E. Lachowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lachowicz, Jean E., et al.. (2019). Cigarette Smoke-Induced Oxidative Stress and Autophagy in Human Alveolar Epithelial Cell Line (A549 Cells). Advances in experimental medicine and biology. 1176. 63–69. 9 indexed citations
2.
Lachowicz, Jean E., et al.. (2019). Cytotoxicity, Oxidative Stress, and Autophagy in Human Alveolar Epithelial Cell Line (A549 Cells) Exposed to Standardized Urban Dust. Advances in experimental medicine and biology. 1176. 101–108. 10 indexed citations
3.
Régina, Anthony, Michel Demeule, Sasmita Tripathy, et al.. (2014). ANG4043, a Novel Brain-Penetrant Peptide–mAb Conjugate, Is Efficacious against HER2-Positive Intracranial Tumors in Mice. Molecular Cancer Therapeutics. 14(1). 129–140. 88 indexed citations
4.
Shao, Ning, Robert Aslanian, Robert E. West, et al.. (2012). Synthesis and structure–activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(5). 2075–2078. 4 indexed citations
5.
Xiao, Dong, Anandan Palani, Robert Aslanian, et al.. (2012). Fused bicycles as arylketone bioisosteres leading to potent, orally active thiadiazole H3 antagonists. Bioorganic & Medicinal Chemistry Letters. 22(9). 3354–3357. 3 indexed citations
6.
Deng, Yongqi, Zhiwei Yang, Gerald W. Shipps, et al.. (2012). Discovery of liver-targeted inhibitors of stearoyl-CoA desaturase (SCD1). Bioorganic & Medicinal Chemistry Letters. 23(3). 791–796. 15 indexed citations
7.
Ting, Pauline C., Nicolas F. Zorn, Hyunjin M. Kim, et al.. (2012). Lead optimization of a pyridine-carboxamide series as DGAT-1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(4). 985–988. 8 indexed citations
8.
Xiao, Dong, Cheng Wang, Anandan Palani, et al.. (2010). Discovery of a series of potent, orally active α,α-disubstituted piperidine NK1 antagonists. Bioorganic & Medicinal Chemistry Letters. 20(21). 6313–6315. 10 indexed citations
9.
Palani, Anandan, Xiao Cheng, Ying Huang, et al.. (2009). Synthesis and structure–activity relationships of 2-(1,4′-bipiperidin-1′-yl)thiazolopyridine as H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(21). 6176–6180. 32 indexed citations
10.
11.
Reichard, Gregory A., Sunil Paliwal, Sapna Shah, et al.. (2006). Cyclobutane derivatives as potent NK1 selective antagonists. Bioorganic & Medicinal Chemistry Letters. 16(14). 3859–3863. 45 indexed citations
12.
Shue, Ho‐Jane, Xiao Chen, Neng‐Yang Shih, et al.. (2005). Cyclic urea derivatives as potent NK1 selective antagonists. Bioorganic & Medicinal Chemistry Letters. 15(17). 3896–3899. 40 indexed citations
13.
Bryant, Robert W., et al.. (2004). WGA-Coated Yttrium Oxide Beads Enable an Imaging-Based Adenosine 2a Receptor Binding Scintillation Proximity Assay Suitable for High Throughput Screening. Assay and Drug Development Technologies. 2(3). 290–299. 8 indexed citations
14.
Holmes, Andrew, Jean E. Lachowicz, & David R. Sibley. (2004). Phenotypic analysis of dopamine receptor knockout mice; recent insights into the functional specificity of dopamine receptor subtypes. Neuropharmacology. 47(8). 1117–1134. 97 indexed citations
15.
McCombie, Stuart W., Jayaram R. Tagat, Dennis V. Nazareno, et al.. (2002). Synthesis and structure–Activity relationships of M2-Selective muscarinic receptor ligands in the 1-[4-(4-Arylsulfonyl)-phenylmethyl]-4-(4-piperidinyl)-piperazine family. Bioorganic & Medicinal Chemistry Letters. 12(5). 795–798. 8 indexed citations
16.
Duffy, Ruth A., Geoffrey B. Varty, Cynthia A. Morgan, & Jean E. Lachowicz. (2002). Correlation of Neurokinin (NK) 1 Receptor Occupancy in Gerbil Striatum with Behavioral Effects of NK1 Antagonists. Journal of Pharmacology and Experimental Therapeutics. 301(2). 536–542. 47 indexed citations
17.
Luo, Lin, Eric L. Gustafson, Jean E. Lachowicz, et al.. (2001). ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999. Journal of Biological Chemistry. 276(11). 8608–8615. 178 indexed citations
18.
Foster, Carolyn, Ying Zhai, Michelle Smith, et al.. (2001). Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. Journal of Clinical Investigation. 107(12). 1591–1598. 330 indexed citations
19.
Lachowicz, Jean E., Derek Lowe, Ruth A. Duffy, et al.. (1999). SCH 57790: A novel M2 receptor selective antagonist. Life Sciences. 64(6-7). 535–539. 19 indexed citations
20.
Lachowicz, Jean E., et al.. (1994). The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.. Molecular Pharmacology. 45(5). 878–889. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas A. Pugsley Breakdown of academic impact, for papers by Marlene A. Jacobson Breakdown of academic impact, for papers by Douglas J. Pettibone Breakdown of academic impact, for papers by Richard W. Ransom Breakdown of academic impact, for papers by Hiroshi Kase Breakdown of academic impact, for papers by Daphné Atlas Breakdown of academic impact, for papers by Gunnar Schulte Breakdown of academic impact, for papers by Diana L. Donnelly‐Roberts Breakdown of academic impact, for papers by Björn Kull Breakdown of academic impact, for papers by Robert H. Scannevin
Rankless by CCL
2026